Balanced news tone
News Sentiment
AMG sentiment intelligence
Amgen Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
52
Balanced news tone
16 relevant articles
News tone and price action are not far from neutral.
84/100 classification confidence.
directly relevant articles
high-authority source matches
-2.5% over one week, +4.0% over four weeks, trend active, and near fair-value range.
Amgen Inc (AMGN) Stock Up 3.7% but GF Value Says Overvalued -- GF Score: 81/100
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
84/100 classification
One-week reaction
-2.5%
Price reacting lower
Trend fit
Trend active
4.0% over four weeks
Fair value
22.7%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
2
Neutral
12
Negative
2
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
GuruFocus
Direct company coverage
Amgen Inc (AMGN) Stock Up 3.7% but GF Value Says Overvalued -- GF Score: 81/100
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 21:25
- Source
- GuruFocus
MarketBeat
Direct company coverage
AMG National Trust Bank Has $4.59 Million Stock Position in Amgen Inc. $AMGN
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 07:40
- Source
- MarketBeat
Investing.com Canada
Direct company coverage
Guggenheim raises Amgen stock price target to $343 on product mix
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 13 Jul 2026 11:51
- Source
- Investing.com Canada
ad-hoc-news.de
Direct company coverage
Amgen Inc. Stock (US0311621009): Dow component under pressure after recent pullback
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Jun 2026 07:33
- Source
- ad-hoc-news.de
Stock Titan
Direct company coverage
Amgen CFO and markets chief speak at Goldman Sachs healthcare event
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- Stock Titan
ad-hoc-news.de
Direct company coverage
Amgen Inc. stock (US0311621009): EU lung cancer approval draws focus as shares hold near USD 330
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 03 Jun 2026 07:00
- Source
- ad-hoc-news.de
ad-hoc-news.de
Direct company coverage
Amgen Inc. stock (US0311621009): Shares open lower in New York
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- ad-hoc-news.de
Stock Titan
Direct company coverage
Amgen's CFO and senior execs to speak at Jefferies healthcare event
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- Stock Titan
Investing.com Nigeria
Direct company coverage
Maria Elvira Salazar trades in Amgen, Carrier Global, and Microsoft stocks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 May 2026 01:30
- Source
- Investing.com Nigeria
PR Newswire
Direct company coverage
/C O R R E C T I O N -- Amgen/
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Apr 2026 07:00
- Source
- PR Newswire
Stock Titan
Direct company coverage
Amgen sets June 5 payout for its $2.52 Q2 dividend to shareholders
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 04 Mar 2026 21:02
- Source
- Stock Titan
Forbes
Direct company coverage
Why Amgen Stock Is Paying Off Big For Long-Term Investors
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Feb 2026 08:00
- Source
- Forbes
PR Newswire
Direct company coverage
AMGEN REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 Nov 2025 08:00
- Source
- PR Newswire
Reuters
Direct company coverage
US judge overturns Amgen's $50.3 mln loss in cancer drug patent case
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 14 Aug 2025 07:00
- Source
- Reuters
Clinical Trials Arena
Direct company coverage
Amgen speaks out about bone density concerns with obesity drug
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Nov 2024 08:00
- Source
- Clinical Trials Arena
Reuters
Direct company coverage
Amgen to buy back $6 bln in shares this qtr, provides long-term profit forecast
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 08 Feb 2022 08:00
- Source
- Reuters